Tesla (TSLA)
Executive Summary & Action Plan
Verdict
HOLD — Record revenue, collapsing margins. At 122x EBITDA the stock is an option on robotaxi; the 12M path offers +8.5% at 0.4:1 risk/reward.
Price $339.28 | Market cap $1,340.0B | Target $368 | Upside +8.5% 12M market-path target · intrinsic $57–$160 (blended $121) — see Fair Value · Street $395.34 (n=40, reference; 시장 데이터 aggregate $374.27)
The Take
Tesla just printed record revenue and a 1.4% operating margin in the same quarter. Regulatory credits fell 67%, AI spending pushed capex to $5.8B, and free cash flow went negative for the first time in the series. Yet the stock trades at 122x EBITDA — cash-flow math supports $57–$160 a share, so roughly two-thirds of the price is robotaxi and Optimus option value. We hold. The catalyst chain from Cybercab (late August) through Q3 earnings (October) will either validate that option or reprice it. Trim strength; new money waits for $305.
Action Plan
Trim 25% at the 12M path ($368), 20% more at the 200-day ($404); conditional entry only near the 52-week low; exit review below $290.
- R/R 0.41:1 (12M target $368 vs bear $270 — below 1.5 gate, no new entry) | Prob-weighted 12M +8.5% | Confidence: Medium | p_thesis_wrong 35%
Forecast Path
Bands are widened by the 120% consensus dispersion ($125–600). Probabilities are derived, not default: bear (30%) outweighs bull (25%) because FCF just went negative while the EPS revision cycle points down; the Cybercab and merger tails keep bull at 25%.
By the Charts
Margins have fallen five straight quarters: operating 6.6% → 1.4%; FCF margin turned negative.
Revenue +25.5% YoY, operating income −56.9%: credits (−67%) and AI opex (R&D +49%) did the damage; net income was rescued by $1.0B of non-operating income.
Still 73% a car company: the AI multiple rests on 27% of revenue. Energy margin fell 30.3% → 20.4%.
Cash-flow math tops out at $160 a share; everything above is option value.
Fair Value — Two Layers
Layer 1 is what the cash flows are worth: DCF $57, target EV/EBITDA $160, target EV/FCF $121 — log-median $121, so ~64% of today's price is option value on robotaxi, Optimus and energy. Layer 2 is where the stock can trade in 12 months if that option premium survives the densest catalyst window on the calendar: probability-weighted $368. We never promote Layer 1 to a target — TSLA trades on narrative, and the 120% consensus dispersion is the proof. The two layers differ by +204% because the market prices option success the cash flows have not yet earned. Decomposition: EBITDA growth +60.8% (TTM $10.8B → FY27E $17.3B (E)) × re-rate −32.5% (122x → 82x (E)) × payout 0% = +8.5% vs target gap +8.5% — check 0.0pp ✓.
촉매 캘린더
단기 (0~6개월)
Risks & Thesis Breakers
- Margin/FCF deterioration persists — 60% × −15–25%, 1–2 quarters (capex $5.8B/qtr against $25B+ FY26 guide; Q2 FCF −$1.1B).
- Robotaxi scale failure or delay — 45% × −30–45%, 6–18M (Nevada granted 10 permits of 5,000 requested; Austin fleet stalled ~20 cars).
- Multiple compression — 40% × −20–35% (below SMA50 and SMA200; EPS surprise −38.1%; no valuation anchor at 122x EBITDA).
- Breakers (any voids the HOLD-negative bias): unsupervised paid robotaxi in 3+ cities or fleet >5,000 (E); gross margin ex-credits up two straight quarters with op margin ≥6%; quarterly FCF ≥ +$2B while capex stays ≥$5B; FY27 EPS upgrade cycle begins; xAI/SpaceX combination reaches a formal board/shareholder vote.
Appendix
카탈리스트 · 향후 6개월
면책사항 · 본 IC 메모는 IWANNAVY LAB의 내부 투자 리서치 자료이며, 공개된 정보와 에이전트 기반 분석을 종합한 교육·연구 목적 문서입니다. 투자 권유·매수/매도 추천이 아니며, 모든 투자 판단과 책임은 투자자 본인에게 있습니다. 가격 데이터는 yfinance + Finviz Elite 교차검증으로 2026-08-20 기준이며, 시장 동향에 따라 실시간 변동할 수 있습니다.
Comments are public. Posting is limited to paid members.
Posting is available on LAB Pro
Sign in, then upgrade to join the discussion.
Loading comments...